Citius Pharmaceuticals, Inc.
CTXR
$0.85
$0.000.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.17% | 22,964.77% | -97.60% | -66.17% | -81.84% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 29.51% | 12.19% | 6.66% | 73.92% | -- |
| Prepaid Expenses | 6.27% | -56.35% | 5.73% | 5.40% | -73.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.50% | 33.94% | 0.26% | 28.88% | -49.22% |
|
|
|||||
| Total Current Assets | 13.50% | 33.94% | 0.26% | 28.88% | -49.22% |
| Net Property, Plant & Equipment | -7.04% | -4.49% | 381.77% | -22.26% | -17.91% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 56.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 2.55% | 5.10% | 0.64% | 3.47% | 20.15% |
|
|
|||||
| Total Accounts Payable | 35.66% | 7.75% | 27.21% | 49.46% | 196.23% |
| Total Accrued Expenses | -38.84% | 2.26% | 35.37% | 293.47% | -0.32% |
| Short-term Debt | 0.00% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -23.02% | -20.95% | -29.08% | -15.28% | 2.50% |
| Total Finance Division Other Current Liabilities | -20.25% | 0.00% | 0.00% | 0.00% | -- |
| Total Other Current Liabilities | -20.25% | 0.00% | 0.00% | 0.00% | -- |
| Total Current Liabilities | -13.36% | 3.94% | 11.32% | 25.10% | 762.57% |
|
|
|||||
| Total Current Liabilities | -13.36% | 3.94% | 11.32% | 25.10% | 762.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 0.00% | -- | -- | -- | -- |
| Capital Leases | -5.49% | -2.50% | -- | -- | -74.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.52% | 3.65% | 3.79% | 3.94% | 2.19% |
| Total Liabilities | -11.15% | 3.82% | 11.82% | 21.70% | 293.75% |
|
|
|||||
| Common Stock & APIC | 3.53% | 4.67% | 2.23% | 1.88% | -1.74% |
| Retained Earnings | -3.45% | -3.96% | -5.17% | -4.85% | -5.66% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.83% | 7.25% | -7.26% | -6.66% | -18.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.83% | 7.25% | -7.26% | -6.66% | -18.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 298.71% | -14.20% | -16.94% | -12.75% | 570.29% |
| Total Equity | 14.75% | 6.27% | -7.75% | -6.99% | -14.12% |
|
|
|||||